Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Dementia Care Research and Psychosocial Factors.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Drug Development.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Juliana de Oliveira Alves1

  • 1Universidade Feevale, Novo Hamburgo, Rio Grande do Sul, Brazil.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
概括
此摘要是机器生成的。

新型数字工具对早期阿尔茨海默病 (AD) 检测充满希望. 这些快速,敏感的评估,包括数字时钟和回忆 (DCR) 测试和基于智能手机的TapTalk,提供可访问的痴呆症查,特别是在初级保健中.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经学 神经学
  • 老年学是指老年学的学科.
  • 生物标志物研究 生物标志物研究

背景情况:

  • 阿尔茨海默病 (AD) 和其他痴呆症代表着一个日益增长的全球健康挑战,其流行率越来越高.
  • 早期检测,特别是在临床前阶段,对于有效的干预来减缓疾病进展至关重要.
  • 传统的认知测试,如迷你精神状态检查 (MMSE),在敏感度,速度和易受人口因素的影响方面存在局限性,这凸显了需要改进痴呆症查工具的需要.

研究的目的:

  • 评估新的数字评估工具和生物标志物,用于早期和准确地检测阿尔茨海默病 (AD).
  • 将新选方法与传统认知评估的有效性进行比较.
  • 探索在初级保健机构中用于痴呆症查的可访问,快速工具的潜力.

主要方法:

  • 从Medline数据库中对过去五年内发表的三项研究进行了综述.
  • 对MMSE进行数字时钟和回忆 (DCR) 测试的评估,用于识别轻度认知障碍 (MCI) 和早期痴呆症.
  • 基于智能手机的TapTalk (将语音/运动分析与p-tau181生物标志物结合起来) 和在线TAS测试 (将运动认知功能与p-tau181整合起来) 的研究,用于临床前AD风险评估.

主要成果:

  • 与MMSE相比,DCR测试在MCI检测方面表现出更高的准确性和灵敏性,施用时间更短,人口影响更小.
  • TapTalk通过手动和语音模式识别了临床前AD风险,表明其作为非侵入性工具的潜力.
  • 塔斯测试成功检测到认知症状之前的微妙运动变化,这对于早期的阿尔茨海默病阶段非常有用.

结论:

  • 数字评估和生物标志物为早期AD检测提供了创新,敏感和可访问的方法.
  • 这些新的方法有可能显著改善痴呆症查过程.
  • 在初级保健中广泛采用可以使早期干预和更好地管理阿尔茨海默病.